This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland
Menu

Jörg Kittelmann, Ph.D.
Principal Scientist, CMC Downstream API Development at Novo Nordisk
Speaker

Profile

Jörg Kittelmann is a Principal Scientist at Novo Nordisk specializing in purification process development and scaling for peptides and proteins. He has over 8 years of experience at the company and focuses on process analytical technology implementation and overall process sustainability. Jörg holds a PhD in Biotechnology from Delft University of Technology.

Agenda Sessions

  • A Generalized PAT Approach for Fast Peptide Purification Process Development and Production Control in CMC Settings

    , 15:00
    View Session

At this event

Prev
Next
Bart Klein
Senior VP of Axiomer Technology
ProQR Therapeutics

See Jörg at TIDES Europe: Oligonucleotide and Peptide Therapeutics